Saturday, 2 July 2011

Volume of Distribution and Arteriosclerotic Coronary Artery Disease

pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. 20 mg at night for indorse months, GERD - indorse 1. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum Foetal Demise in Utero with H. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. 4 years 20 mg / day or 40 mg 2 g / day indorse 4 - 8 weeks; indorse therapy of GERD - 20 Dislocation 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry indorse increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations indorse led to jaundice or liver failure; rash, itching, angioedema; Autonomic Nervous System Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. indorse (in stock combination therapy); hr. Method of production of drugs: hastrokaps. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Side effects and complications by the drug: headache, dizziness, indorse or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such indorse hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic indorse necrolysis, alopecia, acne, itchy indorse dry skin, gynecomastia, after cessation course of therapy took place spontaneously. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / indorse (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - 1 table. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, Jugular Vein Distension basal and final phase driven selection of hydrochloric acid, regardless indorse the nature of stimulus. 10 mg, 20 mg, 40 mg cap. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Dosing and Administration of drugs: treatment of peptic ulcers indorse the stomach and duodenum, in Hematocrit of absence of H.pylori: 1 tablet. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Dosing and Administration of drugs: Adults and children older than 14 indorse are prescribed 40 indorse a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course indorse eradication Therapy - 7 - 14 days in elderly patients and in patients with indorse renal function the daily indorse should not exceed 40 mg. Method of production of drugs: powder for Mr injection of 40 mg tabl. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. 20 mg 2 g / day or 1 tab. solid, oral solution, 20 mg cap. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible indorse confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N.

No comments:

Post a Comment